Alere Enhances Board of Directors With Appointment Of Gregg J. Powers

    Alere Enhances Board of Directors With Appointment Of Gregg J. Powers

PR Newswire

WALTHAM, Mass., Aug. 22, 2013

WALTHAM, Mass., Aug. 22, 2013 /PRNewswire/ -- Alere Inc. (NYSE: ALR) (the
"Company" or "Alere") is pleased to announce that on August 19, 2013 its Board
of Directors appointed Mr. Gregg J. Powers as an independent director of the
Company. With the addition of Mr. Powers, Alere's Board is now comprised of a
total of 11 directors, 9 of whom are independent.

Mr. Powers is Chairman and Chief Executive Officer of Private Capital
Management ("PCM"), an independent investment advisor. PCM clients own
approximately 941,570 shares of Alere common stock and approximately 5,400
shares of Alere preferred stock, and Mr. Powers owns 46,000 shares of Alere
common stock and 18,608 shares of Alere preferred stock.

"Gregg's appointment is in response to stockholder feedback regarding the
importance of direct stockholder representation, and I expect that he will be
a valuable contributor to the board's discussions about how best to enhance
stockholder value," said Ron Zwanziger, Chairman, Chief Executive Officer and
President of the Company. "This is one step among many towards demonstrating
our continuing commitment to stockholders and to delivering results."

About Gregg J. Powers

Gregg J. Powers is Chairman and Chief Executive Officer of PCM. Mr. Powers
began his investment career as a healthcare analyst at Raymond James
Financial. Mr. Powers joined PCM's investment research team in 1988. During
the early 1990s, Mr. Powers became co-portfolio manager, credited with the
primary underwriting of PCM's investments in technology, healthcare, and
telecommunications. Mr. Powers became President of PCM in 1999, CEO in 2008,
and assumed the role of Chairman in 2009. As portfolio manager, Mr. Powers
oversees all aspects of the investment of client portfolios. Mr. Powers has a
Bachelor of Science degree in Finance from the University of Florida.

About Alere

By developing new capabilities in near-patient diagnosis, monitoring and
health information technology, Alere enables individuals to take charge of
improving their health and quality of life at home. Alere's global leading
products and services, as well as its new product development efforts, focus
on cardiology, infectious disease, toxicology and diabetes. Alere is
headquartered in Waltham, Massachusetts. For more information regarding Alere
please visit

SOURCE Alere Inc.

Contact: Doug Guarino, Director of Corporate Relations, 781-647-3900, Jon
Russell, Vice President of Finance
Press spacebar to pause and continue. Press esc to stop.